Look for Drug Pricing, Other Government Changes–But Be Prepared to Wait

By on April 15, 2021

Political divisiveness on Capitol Hill, a focus on impeachment activity and financial relief for the COVID-19 pandemic—as well as delays in confirming President Joe Biden’s nominees for cabinet and subcabinet positions—so far have caused a slowdown in the new administration’s ability to make sweeping changes affecting healthcare.

In an article for Pharmacy Practice News, McDermott partner James Kim discusses key issues to watch from Congress and the White House in 2021.

Access the article.

James W. KimJames W. Kim
James W. Kim represents clients in a wide variety of matters related to government contracting, with a particular focus on cases involving the healthcare industry. Read James W. Kim's full bio.

STAY CONNECTED

TOPICS

ARCHIVES